Follow us on:
Breaking News
20-10-2026
Breaking News
Breaking News

Longhorn Vaccines and Diagnostics Names Dr. Vijay Singh Chief Scientific Officer

 
Longhorn Vaccines and Diagnostics Names Dr. Vijay Singh Chief Scientific Officer

Singh will help drive expansion of Longhorn’s PrimeStore MTM, a sample collection device.
Read More >>

test

Breaking News
Collaborations & Alliances

ExploRNA, Łukasiewicz Research Network Partner on GMP Manufacturing of Next-Gen mRNA Cap Analogs

Łukasiewicz, known for advanced chemical synthesis and production scaling capabilities, will help ExploRNA ramp up its mRNA manufacturing.

Breaking News

Lilly Breaks Ground on $6.5B Houston Manufacturing Site

The new Texas facility will produce Lilly’s oral GLP-1 medicine Foundayo and other small-molecule therapies.

Breaking News

FDA Approves IntraBio’s Aqneursa as First Treatment for Ataxia-Telangiectasia

It is the second FDA-approved indication for Aqneursa, following Niemann-Pick disease type C.

Breaking News
Promotions & Moves

Mirum Pharmaceuticals Names Rob Myers Chief Medical Officer

Myers comes from OrsoBio, where he was Chief Medical Officer as well as Head of Development.

Featured Resources

Solution Center SPOTLIGHT

Covectra

Covectra provides “bow-to-stern" serialization solutions for better ROI. Covectra’s AuthentiTrack® provides a comprehensive and modular approach to serialize down to the unit of use. AuthentiTrack® software has been awarded the EPCIS mark by the EPCGlobal Software Certification Program, a standards-based compliance testing program sponsored by the GS1 organization. ControlTrack® is a serialization-based solution to track down to the unit of use from the point of sale into the hands of the patient.

 

Solution Center SPOTLIGHT

Simtra BioPharma Solutions

As a premier, independently owned CDMO with over 65+ years of sterile injectable manufacturing experience, Simtra BioPharma Solutions (Simtra) offers world-class cGMP sterile fill/finish, technical expertise, quality service, and a uniquely collaborative approach. Pharmaceutical and biotech companies partner with Simtra when they face formulation challenges, clinical supply hurdles, surges in demand due to market fluctuations, or risk mitigation concerns. Our teams are driven to offer clients tailored and versatile solutions to help them bring their products to market.